Diabetic ketoacidosis in the pediatric ICU

James P Orlowski1, Cheryl L Cramer, Mariano R Fiallos

  • 1Pediatric Intensive Care Unit, University Community Hospital, 3100 East Fletcher Avenue, Tampa, FL 33613, USA. jorlowski@mail.uch.org

Insights

Diabetic ketoacidosis (DKA) is a serious diabetes complication in children. This article details DKA assessment and treatment in pediatric intensive care units, focusing on neurological changes like coma and cerebral edema.

Area of Science:

  • Pediatric Endocrinology
  • Critical Care Medicine
  • Neurology

Background:

  • Diabetic ketoacidosis (DKA) is a frequent and life-threatening complication of diabetes mellitus in pediatric patients.
  • Central nervous system (CNS) alterations, including altered sensorium (diabetic coma) and cerebral edema, are significant concerns in DKA.
  • Cerebral edema in DKA presents a high morbidity and mortality risk.

Purpose of the Study:

  • To outline the assessment and management strategies for pediatric DKA.
  • To highlight the neurological manifestations and complications of DKA in children.
  • To provide guidance for clinicians managing DKA in a pediatric intensive care unit (PICU) setting.

Main Methods:

  • Review of current literature and clinical guidelines on DKA management in children.
  • Discussion of diagnostic criteria and monitoring parameters for DKA.
  • Emphasis on the recognition and treatment of CNS complications, particularly cerebral edema.

Main Results:

  • DKA requires prompt recognition and aggressive management to prevent severe outcomes.
  • Neurological assessment is crucial for identifying altered sensorium and early signs of cerebral edema.
  • Specific treatment protocols are necessary for managing DKA and its neurological sequelae in the PICU.

Conclusions:

  • Effective management of DKA in pediatric patients necessitates a multidisciplinary approach.
  • Vigilant monitoring and timely intervention are key to improving outcomes for children with DKA.
  • Understanding and addressing CNS changes are paramount in reducing DKA-related morbidity and mortality.

Related Concept Videos

Diabetic Ketoacidosis l: Introduction01:25

Diabetic Ketoacidosis l: Introduction

DefinitionDiabetic ketoacidosis (DKA) is an acute, life-threatening complication of diabetes mellitus, characterized by a triad of hyperglycemia (blood glucose >250 mg/dL), ketonemia or ketonuria, and metabolic acidosis (arterial pH <7.30 and serum bicarbonate <18 mEq/L). It results from insulin deficiency combined with elevated levels of counterregulatory hormones—glucagon, catecholamines, cortisol, and growth hormone—leading to increased lipolysis, hepatic ketone production, and...
Diabetic Ketoacidosis ll: Pathophysiology01:22

Diabetic Ketoacidosis ll: Pathophysiology

Diabetic ketoacidosis (DKA) is a metabolic emergency characterized by hyperglycemia, ketonemia, and metabolic acidosis. It results from severe insulin deficiency and an excess of counterregulatory hormones, leading to uncontrolled lipolysis, ketogenesis, and widespread electrolyte and fluid disturbances.Pathophysiology The central event in DKA is a profound loss of insulin action. Without insulin, glucose uptake in insulin-dependent tissues is impaired, while hepatic glucose production...
Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
Diagnosing Acidosis and Alkalosis01:24

Diagnosing Acidosis and Alkalosis

Diagnosing acid-base imbalances involves systematically analyzing arterial blood samples, focusing on three key measurements: pH, bicarbonate (HCO3−) concentration, and carbon dioxide partial pressure (PCO2). This analysis follows a four-step process that helps identify the imbalance's underlying cause and nature.
First, the pH level is assessed to determine whether the blood pH is normal (7.35–7.45), low (acidosis), or high (alkalosis).
Next, the PCO2  and HCO3−  values are examined to...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Hyperosmolar Hyperglycemic State01:21

Hyperosmolar Hyperglycemic State

Hyperosmolar Hyperglycemic State, or HHS, is a serious and life-threatening complication of type 2 diabetes mellitus. It is characterized by three main features: severe hyperglycemia, profound dehydration, and elevated serum osmolality, all occurring without significant ketoacidosis.HHS typically develops in older adults or individuals with limited access to fluids. This may result from illness, cognitive impairment, or medications such as diuretics or corticosteroids. These factors reduce...